Drug-Induced Liver Injury Resources and Reporting for the Clinician.

Marisa Isaacson, Michael Babich

Journal: Clinics in liver disease 2021;24(1):131-139

PMID: 31753246

Full Text on Elsevier Science View on PubMed

Abstract

Although many risk factors for developing drug-induced liver injury (DILI) have been identified and more than 1000 medications and herbal and dietary supplements are known to cause liver dysfunction, idiosyncratic drug reactions remain unpredictable and erratic. Varying effects of individual drugs on the event cascade and patient genetic polymorphisms lead to different clinical presentations. Mechanisms and causality scales have been developed to guide the clinician in diagnosis, and several databases and registries are available for reference and reporting. We identify and summarize the resources available to clinicians to help diagnose, manage, and report DILI and to identify hepatotoxic drugs.

Address: Department of Gastroenterology and Hepatology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA. Electronic address: [email protected].; Department of Gastroenterology and Hepatology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA.

DOI: 10.1016/j.cld.2019.09.010

Link outs

Free resources

Medical:

https://medlineplus.gov/drugreactions.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Chemical and Drug Induced Liver Injury, Databases, Pharmaceutical, Drug Information Services, Humans, Information Storage and Retrieval, Pharmaceutical Services, Online, Registries, Risk Assessment